Key Takeaways
- D-Wave Quantum (QBTS) shares have plummeted approximately 40% year-to-date in 2026, trading at $16.41 as of Tuesday’s close, representing a 2.50% daily decline.
- The company secured a definitive agreement with the U.S. Department of Commerce for up to $100M in non-dilutive CHIPS and Science Act funding.
- Second quarter 2026 revenue totaled $3.1M, falling short of analyst expectations of $4M and marking a marginal year-over-year decrease of less than 1%.
- The company will present its quantum computing dual-platform approach at Quantum World Congress 2026, taking place September 23-25 in College Park, Maryland.
- Analyst consensus shows a Strong Buy rating with a $35.46 average target price, representing potential upside of approximately 116%.
D-Wave Quantum (QBTS) faces significant headwinds in 2026. Since the start of the year, shares have declined roughly 40%, finishing Tuesday’s session at $16.41, and disappointing second-quarter results have only intensified investor concerns.
The company reported second-quarter 2026 revenue of $3.1 million, significantly trailing Wall Street’s $4 million consensus estimate. The figure also reflected a modest year-over-year contraction of less than 1%, particularly disappointing given that several competing quantum computing firms achieved triple-digit percentage revenue growth during the identical timeframe.
Management attributed the revenue miss to timing issues. Expected customer contracts either didn’t materialize or weren’t finalized within the quarter. This underscores a persistent challenge: D-Wave’s revenue stream remains lumpy and dependent on a limited customer base, creating unpredictability in quarterly performance.
Meanwhile, IonQ, a direct competitor in the quantum computing space, delivered robust earnings for the same quarter, underscoring an expanding divide between quantum companies successfully monetizing market interest and those still struggling to generate consistent revenue.
Over just the past 30 days, D-Wave’s stock has declined approximately 17%, with the Q2 earnings disappointment serving as the primary driver behind this recent selloff.
Federal CHIPS Act Award Provides Strategic Support
On September 14, D-Wave completed a binding agreement with the U.S. Department of Commerce, obtaining access to as much as $100 million through the CHIPS and Science Act program.
CEO Dr. Alan Baratz characterized the funding as evidence that federal authorities are committed to advancing quantum technology commercialization and scaling efforts, moving beyond purely academic research initiatives.
Importantly, this capital comes without dilution, meaning D-Wave won’t need to create additional shares to access these funds. This structure protects current shareholders while providing third-party validation during a period of market uncertainty.
While the funding won’t deliver immediate financial transformation, it should accelerate research and development initiatives and potentially strengthen credibility with prospective enterprise clients evaluating quantum solutions.
Company Showcases Technology at Major Industry Event
D-Wave has committed as a platinum sponsor for the Quantum World Congress 2026, scheduled to run from September 23-25 in College Park, Maryland.
During the conference, the company intends to highlight real-world commercial applications of its annealing quantum systems, which currently serve optimization use cases for both private sector and government clients. The company will also provide updates regarding its gate-model quantum computing platform.
Chief Science Officer Robert Schoelkopf is slated to deliver a keynote presentation on September 25, discussing D-Wave’s bifurcated platform strategy and recent advancements in hardware-based erasure detection—a technique the company believes can significantly decrease both costs and complexity associated with quantum error correction.
Conference attendees will have access to live demonstrations of both the company’s annealing and gate-model quantum processing architectures.
Despite this positive industry presence, QBTS shares dropped an additional 0.30% as the week began.
Based on data from TipRanks, 14 Wall Street analysts have issued Strong Buy recommendations on QBTS within the last three months, establishing an average price target of $35.46—suggesting potential upside of approximately 116% from the current trading price.



